MedPath

Andersson, Sture

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Cesarean Section and Intestinal Flora of the Newborn

Not Applicable
Completed
Conditions
Intestinal Microbiome
First Posted Date
2018-06-26
Last Posted Date
2019-02-11
Lead Sponsor
Sture Andersson
Target Recruit Count
7
Registration Number
NCT03568734
Locations
🇫🇮

Helsinki University Hospital, Helsinki, Uusimaa, Finland

Inhaled Salbutamol in Elective Caesarean Section

Phase 4
Conditions
Cesarean Section
Postnatal Pulmonary Adaptation
Interventions
Drug: Placebo
First Posted Date
2013-11-07
Last Posted Date
2014-12-08
Lead Sponsor
Sture Andersson
Target Recruit Count
62
Registration Number
NCT01978418
Locations
🇫🇮

Women's Hospital, Helsinki, Finland

News

No news found
© Copyright 2025. All Rights Reserved by MedPath